Seeking Alpha

Coya Therapeutics Receives Clinical Trial Application (CTA) Acceptance from Health Canada to Proceed with the COYA 302 ALSTARS Trial for the Treatment of Amyotrophic Lateral ...

The CTA No Objection Letter from Health Canada allows for initiation of patient enrollment in the ALSTARS Trial at Canadian ALS centers. The ALSTARS Trial is a phase 2, placebo-controlled study that ...
Seeking Alpha

Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply

Calgary, Alberta, September 4, 2025 –TheNewswire -Universal Ibogaine Inc. (IBO:CA) (TSXV: IBO, in USA: IBOGF, in Germany FSE:JC4) (“UI” or the “Company) is pleased to announce its intention to file, ...
ALS News Today

COYA 302 trial in ALS expands to Canada after regulatory nod

Health Canada has cleared the way for ALS patients in that nation to join the ongoing ALSTARS U.S. trial testing therapy ...
Hosted on MSN

Coya announces Health Canada acceptance of COYA 302 clinical trial application

Coya Therapeutics (COYA) announced that Health Canada has accepted, without objection, the clinical trial application for COYA 302 for the treatment of amyotrophic lateral sclerosis. The CTA ...
Business Wire

Health Canada Approves WELLEX for Human Clinical Trial, Investigating Natural Cervical Health Supplement Papillex®

TORONTO--(BUSINESS WIRE)--WELLEX, in collaboration with Natural Products Canada, is pleased to announce that Health Canada has granted approval to proceed with a human clinical trial on its flagship ...